Actively Recruiting

Age: 21Years +
All Genders
NCT05691868

Vantage Mobile Bearing Total Ankle System Post Market Clinical Follow-up (Outside US)

Led by Exactech · Updated on 2025-02-27

400

Participants Needed

2

Research Sites

651 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The objectives of this study are to evaluate the performance and safety of the Vantage Mobile-Bearing Total Angle System. This study will follow subjects for a period of up to 10 years post-surgery.

CONDITIONS

Official Title

Vantage Mobile Bearing Total Ankle System Post Market Clinical Follow-up (Outside US)

Who Can Participate

Age: 21Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient is indicated for total ankle arthroplasty
  • Patient is at least 21 years of age
  • Patient is likely to be available for follow-up out to 10 years
  • Patient is willing to participate by complying with pre- and postoperative visit requirements
  • Patient is willing and able to read and sign a study informed consent form
Not Eligible

You will not qualify if you...

  • Patient with excessive bone loss at the ankle joint site
  • Patient with severe osteoporosis
  • Patient with complete talar avascular necrosis
  • Patient with active osteomyelitis
  • Patient with infection at the ankle site or infection at distant sites that could migrate to the ankle
  • Patient with sepsis
  • Patient with vascular deficiency in the involved limb
  • Pateint with neuropathic joints
  • Patient with neurological or musculoskeletal disease or loss of function that may adversely affect movement of the lower limb, gait, or weight bearing
  • Patient with poor soft tissue coverage around the ankle
  • Patient with Charcot arthropathy
  • Previsous ankle arthrodesis with excision of the malleoli
  • Excessive loads as cuased by activity or patient weight - per investigator discretion
  • Skeletally immature patients (patient is less than 21 years if age at time of surgery)
  • Patient with dementia
  • Patient with known metal allergies
  • Patients who are unwilling to provide informed consent
  • Patients who are unlikely to be available for follow-up out to 10 years
  • Patients who are not deemed suitable candidates for the subject device
  • Patient is pregnant

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Hospital Universitario de Canarias

Santa Cruz de Tenerife, Spain, 38320

Actively Recruiting

2

SWISS ORTHO CENTER Pain Clinic Basel

Basel, Switzerland, CH-4010

Actively Recruiting

Loading map...

Research Team

R

Rachael Craig

CONTACT

S

Sandrine Angibaud

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here